Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Angiodynamics (ANGO) over the last 14 years, with Q4 2025 value amounting to $76.3 million.

  • Angiodynamics' Total Non-Current Liabilities fell 1790.08% to $76.3 million in Q4 2025 from the same period last year, while for Nov 2025 it was $76.3 million, marking a year-over-year decrease of 1790.08%. This contributed to the annual value of $80.3 million for FY2025, which is 1639.15% down from last year.
  • According to the latest figures from Q4 2025, Angiodynamics' Total Non-Current Liabilities is $76.3 million, which was down 1790.08% from $72.6 million recorded in Q3 2025.
  • Angiodynamics' Total Non-Current Liabilities' 5-year high stood at $149.8 million during Q2 2023, with a 5-year trough of $61.7 million in Q3 2023.
  • In the last 5 years, Angiodynamics' Total Non-Current Liabilities had a median value of $96.4 million in 2022 and averaged $101.9 million.
  • Over the last 5 years, Angiodynamics' Total Non-Current Liabilities had its largest YoY gain of 4058.81% in 2023, and its largest YoY loss of 5440.76% in 2023.
  • Angiodynamics' Total Non-Current Liabilities (Quarter) stood at $105.2 million in 2021, then soared by 34.21% to $141.2 million in 2022, then tumbled by 32.15% to $95.8 million in 2023, then dropped by 2.99% to $92.9 million in 2024, then dropped by 17.9% to $76.3 million in 2025.
  • Its Total Non-Current Liabilities was $76.3 million in Q4 2025, compared to $72.6 million in Q3 2025 and $80.3 million in Q2 2025.